The global artificial intelligence (AI) in drug discovery market was evaluated at US$ 1.70 billion in 2023 and is expected to attain around US$ 11.93 billion by 2033, growing at a CAGR of 21.5% from 2024 to 2033.
The global artificial intelligence (AI) in drug discovery market was evaluated at US$ 1.70 billion in 2023 and is expected to attain around US$ 11.93 billion by 2033, growing at a CAGR of 21.5% from 2024 to 2033.